The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis
Open accessAbstract
Background: Chronic plaque-type psoriasis is a major dermatosis, but a significant question is still unanswered: What defines severity in chronic plaque-type psoriasis? While objective assessments like the Psoriasis Area and Severity Index (PASI) have frequently been used in clinical trials, quality of life (QOL) questionnaires are currently becoming more and more popular. Objective: This article summarizes the most important objective and subjective measurements of severity in psoriasis. For every dermatologist it is critically important to distinguish between severe psoriasis and psoriasis that severely affects QOL. Even if the PASI also has disadvantages, it is the most adequate instrument available to evaluate severity in plaque-type psoriasis. Result: We provide reasons why PASI >12 defines severe, PASI 7–12 moderate and PASI <7 mild chronic plaque-type psoriasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
Lebwohl, M., Tyring, S. K., Hamilton, T. K., Toth, D., Glazer, S., Tawfik, N. H., Walicke, P., Dummer, W., Wang, X., Garovoy, M. R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030002 · Cited by 570
T Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset
Schlaak, J. F., Buslau, M., Jochum, W., Hermann, E., Girndt, M., Gallati, H., Büschenfelde, K.-H. M. Z., & Fleischer, B. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371752 · Cited by 455
Lebwohl, M., Christophers, E., Langley, R., Ortonne, J. P., Roberts, J., & Griffiths, C. E. M. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.6.719 · Cited by 363
Psoriasis-an index of disability
FINLAY, A. Y., & KELLY, S. E. (1987) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1987.tb01844.x · Cited by 334
Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis
FINLAY, A. Y., KHAN, G. K., LUSCOMBE, D. K., & SALEK, M. S. (1990) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1990.tb04192.x · Cited by 314
Ashcroft, Po, L. W., Williams, & Griffiths (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02963.x · Cited by 287
The Self-Administered Psoriasis Area and Severity Index Is Valid and Reliable
Feldman, S. R., Fleischer, A. B., Reboussin, D. M., Rapp, S. R., Lyn Exum, M., Clark, A. R., & Nurre, L. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329912 · Cited by 267
The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress.
Gupta, M. A., & Gupta, A. K. (1995) · Acta Dermato-Venereologica · doi:10.2340/0001555575240243 · Cited by 196
Cited by
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Puzenat, E., Bronsard, V, Prey, S., Gourraud, P., Aractingi, S., Bagot, M., Cribier, B., Joly, P., Jullien, D., Le Maitre, M., et al. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03562.x · Cited by 309
Augustin, M., Krüger, K., Radtke, M. A., Schwippl, I., & Reich, K. (2008) · Dermatology · doi:10.1159/000119415 · Cited by 271
Montero-Vilchez, T., Segura-Fernández-Nogueras, M.-V., Pérez-Rodríguez, I., Soler-Gongora, M., Martinez-Lopez, A., Fernández-González, A., Molina-Leyva, A., & Arias-Santiago, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020359 · Cited by 206
A pilot study examining mindfulness-based cognitive therapy in psoriasis
Fordham, B., Griffiths, C. E. M., & Bundy, C. (2015) · Psychology, Health & Medicine · doi:10.1080/13548506.2014.902483 · Cited by 116
Metadata
- Authors
- Schmitt, J., & Wozel, G.
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2005
- Volume
- 210
- Issue
- 3
- Pages
- 194-199
- ISSN
- 1018-8665 (ISSN-L)
- 1421-9832
- OpenAlex
- W2028656318
- Cited by
- 440
- References
- 22
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis. https://app.cochat.ai/papers/10.1159/000083509
- The paper
- Schmitt, J., & Wozel, G. (2005). The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis. Dermatology. https://doi.org/10.1159/000083509
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
